Guardion Health Sciences, Inc. (GHSI)
OTCMKTS
· Delayed Price · Currency is USD
3.220
-0.070 (-2.13%)
Inactive · Last trade price
on Oct 30, 2024
Guardion Health Sciences Revenue
Guardion Health Sciences had revenue of $72.92K in the quarter ending June 30, 2024, a decrease of -8.43%. This brings the company's revenue in the last twelve months to $12.23M, up 119.79% year-over-year. In the year 2023, Guardion Health Sciences had annual revenue of $12.25M with 10.85% growth.
Revenue (ttm)
12.23M
Revenue Growth
+119.79%
P/S Ratio
0.34
Revenue / Employee
1.36M
Employees
9
Market Cap
4.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 12.25M | 1.20M | 10.85% |
| Dec 31, 2022 | 11.05M | 3.82M | 52.77% |
| Dec 31, 2021 | 7.23M | 5.34M | 282.74% |
| Dec 31, 2020 | 1.89M | 986.91K | 109.30% |
| Dec 31, 2019 | 902.94K | -39.22K | -4.16% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.69B |
| Ryman Healthcare Limited | 411.39M |
| Verano Holdings Corp. | 920.97M |
| Vireo Growth Inc. | 98.04M |
| Medexus Pharmaceuticals Inc. | 108.78M |
Guardion Health Sciences News
- 7 weeks ago - Guardion Health Sciences Announces Filing of Certificate of Dissolution - GlobeNewsWire
- 2 months ago - Guardion Health Sciences announces adoption of plan of dissolution and liquidation - Seeking Alpha
- 4 months ago - Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock - GlobeNewsWire
- 4 months ago - Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024 - GlobeNewsWire
- 7 months ago - Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution - GlobeNewsWire
- 7 months ago - Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business - GlobeNewsWire
- 7 months ago - Guardion Health Sciences Announces - GlobeNewsWire
- 9 months ago - Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 - GlobeNewsWire